MTCBX
Price
$45.09
Change
+$0.33 (+0.74%)
Updated
Jul 31 closing price
Net Assets
2.29B
SLMCX
Price
$229.17
Change
+$0.98 (+0.43%)
Updated
Jul 31 closing price
Net Assets
27.54B
Interact to see
Advertisement

MTCBX vs SLMCX

MTCBX vs SLMCX Comparison Chart in %
View a ticker or compare two or three
VS
MTCBX vs. SLMCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTCBX is a Buy and SLMCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SLMCX has more cash in the bank: 27.5B vs. MTCBX (2.3B). MTCBX (0.00) and SLMCX (0.00) have matching dividends . MTCBX was incepted earlier than SLMCX: MTCBX (26 years) vs SLMCX (43 years). MTCBX (1.87) is less costly to investors than SLMCX (1.16). MTCBX is a more actively managed with annual turnover of: 50.00 vs. SLMCX (33.00). MTCBX has a lower initial minimum investment than SLMCX: MTCBX (1000) vs SLMCX (2000). SLMCX annual gain was more profitable for investors over the last year : 66.15 vs. MTCBX (-3.36). SLMCX return over 5 years is better than : 79.67 vs. MTCBX (-25.74).
MTCBXSLMCXMTCBX / SLMCX
Total Expense Ratio1.861.16160%
Annual Report Gross Expense Ratio1.871.16161%
Fund Existence26 years43 years-
Gain YTD12.75346.24828%
Front LoadN/A6%-
Min. Initial Investment1000200050%
Min. Initial Investment IRAN/AN/A-
Net Assets2.3B27.5B8%
Annual Yield % from dividends0.000.00-
Returns for 1 year-3.3666.15-5%
Returns for 3 years11.91106.0011%
Returns for 5 years-25.7479.67-32%
Returns for 10 years84.19294.8529%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DJUL50.530.18
+0.35%
FT Vest US Equity Deep Bffr ETF Jul
SUSA153.160.30
+0.20%
iShares ESG Optimized MSCI USA ETF
RFLR32.31-0.07
-0.22%
Innovator U.S. Small Cp Mgd Flr ETF
HFMF21.48-0.05
-0.22%
Unlimited HFMF Managed Futures ETF
FFTY36.99-0.34
-0.91%
CapForce IBD® 50 ETF